Viral subversion of nucleocytoplasmic trafficking - PubMed (original) (raw)
Review
Viral subversion of nucleocytoplasmic trafficking
Melanie L Yarbrough et al. Traffic. 2014 Feb.
Abstract
Trafficking of proteins and RNA into and out of the nucleus occurs through the nuclear pore complex (NPC). Because of its critical function in many cellular processes, the NPC and transport factors are common targets of several viruses that disrupt key constituents of the machinery to facilitate viral replication. Many viruses such as poliovirus and severe acute respiratory syndrome (SARS) virus inhibit protein import into the nucleus, whereas viruses such as influenza A virus target and disrupt host mRNA nuclear export. Current evidence indicates that these viruses may employ such strategies to avert the host immune response. Conversely, many viruses co-opt nucleocytoplasmic trafficking to facilitate transport of viral RNAs. As viral proteins interact with key regulators of the host nuclear transport machinery, viruses have served as invaluable tools of discovery that led to the identification of novel constituents of nuclear transport pathways. This review explores the importance of nucleocytoplasmic trafficking to viral pathogenesis as these studies revealed new antiviral therapeutic strategies and exposed previously unknown cellular mechanisms. Further understanding of nuclear transport pathways will determine whether such therapeutics will be useful treatments for important human pathogens.
Keywords: mRNA export; nuclear import; nuclear pore complex; nuclear transport; nucleocytoplasmic trafficking; virus.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Figures
Figure 1
Viral strategies to disrupt nucleocytoplasmic trafficking of proteins. Nuclear import pathways mediated by Kapα/Kapβ1 or Kapβ2 are shown. Kapα and Kapβ2 bind proteins or cargos with specific
NLS
s. Kapβ1 and β2 translocate the import complexes through the
NPC
via interactions with Nups. The import complexes are dissociated by
RanGTP
at the nucleoplasmic side of the
NPC
. Viral proteins (blue starbursts) interact with the depicted host factors to disrupt nuclear transport pathways.
2Apro
and
3Cpro
of
HRV
and
PV
degrade Nups and block nuclear import of proteins via the Kapα/β1 and Kapβ2 pathways.
SARS‐CoV ORF6
protein effectively disrupts nuclear import of phosphorylated
STAT1
by tethering
PY‐STAT1
–Kapα/Kapβ complex to
ER
/Golgi membranes. Alternatively,
EBOV‐VP24
binds Kapα preventing its interaction with phosphorylated
STAT1
and
hnRNP C1
/
C2
, which accumulate in the cytoplasm. In
HPV
, while
HPV11 L1
binds Kapβ2/β3 and disrupts cargo import, the viral
HPV16 L2
protein gets imported into nucleus by binding to Kapβ2, Kapβ3 and Kapα/Kapβ1 complex. To inhibit protein import, L protein of
EMCV
hyperphosphorylates Nups and binds Ran.
ICP27
protein of
HSV
interacts with Nup62 and blocks nuclear import of proteins via Kapα/Kapβ1 and Kapβ2 pathways. Disruption of nuclear import of proteins by other viruses is discussed in the text.
Figure 2
Viral disruption of host
mRNA
nuclear export pathways. Host
mRNA
export is coordinated by the
TREX
complex, which consists of
THO
,
UAP56
and
REF
/Aly. The association of
REF
with
mRNA
recruits the
mRNA
export receptor heterodimer
NXF1‐NXT1
, which mediates export of
mRNAs
by interacting with Nups at the
NPC
. Circles surrounding
mRNAs
depict
RNA
‐binding proteins. Viral proteins (depicted as blue starbursts) disrupt
mRNA
nuclear export by interacting with host factors.
IAV NS1
binds and disrupts factors involved in cellular
mRNA
processing and export.
VSV
M protein interacts with Rae1 and Nup98, resulting in
mRNA
nuclear export block.
2Apro
of
PV
and
HRV
cleaves Nups to disrupt
NPC
architecture.
AdV E1B 55K
and
E4orf6
proteins disrupt
NXF1
‐mediated host
mRNA
export by binding to
E1B‐AP5
. Other viruses, such as herpesviruses and
HIV
, utilize cellular transport pathways to promote viral
mRNA
export. The herpesvirus protein
ICP27
facilitates preferential export of viral
mRNAs
through interaction with
REF
/Aly and
NXF1
. The
HIV‐1
Rev protein facilitates nuclear export of unspliced or partially spliced viral
mRNAs
through the Rev‐responsive element (
RRE
), an
RNA
signature on these viral
mRNAs
. Rev‐bound viral
RNA
binds
CRM1
and
RanGTP
and is translocated through the
NPC
.
Similar articles
- How SARS-CoV-2 and Other Viruses Build an Invasion Route to Hijack the Host Nucleocytoplasmic Trafficking System.
Sajidah ES, Lim K, Wong RW. Sajidah ES, et al. Cells. 2021 Jun 7;10(6):1424. doi: 10.3390/cells10061424. Cells. 2021. PMID: 34200500 Free PMC article. Review. - Regulated nucleocytoplasmic trafficking of viral gene products: a therapeutic target?
Alvisi G, Rawlinson SM, Ghildyal R, Ripalti A, Jans DA. Alvisi G, et al. Biochim Biophys Acta. 2008 Jan;1784(1):213-27. doi: 10.1016/j.bbapap.2007.08.021. Epub 2007 Aug 31. Biochim Biophys Acta. 2008. PMID: 17933596 Review. - Viral Subversion of the Chromosome Region Maintenance 1 Export Pathway and Its Consequences for the Cell Host.
Mghezzi-Habellah M, Prochasson L, Jalinot P, Mocquet V. Mghezzi-Habellah M, et al. Viruses. 2023 Nov 6;15(11):2218. doi: 10.3390/v15112218. Viruses. 2023. PMID: 38005895 Free PMC article. Review. - The Role of Protein Disorder in Nuclear Transport and in Its Subversion by Viruses.
Wubben JM, Atkinson SC, Borg NA. Wubben JM, et al. Cells. 2020 Dec 10;9(12):2654. doi: 10.3390/cells9122654. Cells. 2020. PMID: 33321790 Free PMC article. Review. - Viral interactions with the nuclear transport machinery: discovering and disrupting pathways.
Fontoura BM, Faria PA, Nussenzveig DR. Fontoura BM, et al. IUBMB Life. 2005 Feb;57(2):65-72. doi: 10.1080/15216540500078608. IUBMB Life. 2005. PMID: 16036565 Review.
Cited by
- Insights into the role of Nup62 and Nup93 in assembling cytoplasmic ring and central transport channel of the nuclear pore complex.
Madheshiya PK, Shukla E, Singh J, Bawaria S, Ansari MY, Chauhan R. Madheshiya PK, et al. Mol Biol Cell. 2022 Dec 1;33(14):ar139. doi: 10.1091/mbc.E22-01-0027. Epub 2022 Oct 12. Mol Biol Cell. 2022. PMID: 36222862 Free PMC article. - Molecular mechanism underlying selective inhibition of mRNA nuclear export by herpesvirus protein ORF10.
Feng H, Tian H, Wang Y, Zhang Q, Lin N, Liu S, Yu Y, Deng H, Gao P. Feng H, et al. Proc Natl Acad Sci U S A. 2020 Oct 27;117(43):26719-26727. doi: 10.1073/pnas.2007774117. Epub 2020 Oct 8. Proc Natl Acad Sci U S A. 2020. PMID: 33033226 Free PMC article. - Gating Immunity and Death at the Nuclear Pore Complex.
Dasso M, Fontoura BMA. Dasso M, et al. Cell. 2016 Sep 8;166(6):1364-1366. doi: 10.1016/j.cell.2016.08.026. Cell. 2016. PMID: 27610561 Free PMC article. - Pair correlation microscopy reveals the role of nanoparticle shape in intracellular transport and site of drug release.
Hinde E, Thammasiraphop K, Duong HT, Yeow J, Karagoz B, Boyer C, Gooding JJ, Gaus K. Hinde E, et al. Nat Nanotechnol. 2017 Jan;12(1):81-89. doi: 10.1038/nnano.2016.160. Epub 2016 Sep 12. Nat Nanotechnol. 2017. PMID: 27618255 - Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.
Kehrer T, Cupic A, Ye C, Yildiz S, Bouhaddou M, Crossland NA, Barrall EA, Cohen P, Tseng A, Çağatay T, Rathnasinghe R, Flores D, Jangra S, Alam F, Mena I, Aslam S, Saqi A, Rutkowska M, Ummadi MR, Pisanelli G, Richardson RB, Veit EC, Fabius JM, Soucheray M, Polacco BJ, Ak B, Marin A, Evans MJ, Swaney DL, Gonzalez-Reiche AS, Sordillo EM, van Bakel H, Simon V, Zuliani-Alvarez L, Fontoura BMA, Rosenberg BR, Krogan NJ, Martinez-Sobrido L, García-Sastre A, Miorin L. Kehrer T, et al. Cell Host Microbe. 2023 Oct 11;31(10):1668-1684.e12. doi: 10.1016/j.chom.2023.08.003. Epub 2023 Sep 21. Cell Host Microbe. 2023. PMID: 37738983 Free PMC article.
References
- Raices M, D'Angelo MA. Nuclear pore complex composition: a new regulator of tissue‐specific and developmental functions. Nat Rev Mol Cell Biol 2012;13:687–699. - PubMed
- Suntharalingam M, Wente SR. Peering through the pore: nuclear pore complex structure, assembly, and function. Dev Cell 2003;4:775–789. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 AI089539/AI/NIAID NIH HHS/United States
- T32-CA124334/CA/NCI NIH HHS/United States
- R01 AI079110/AI/NIAID NIH HHS/United States
- T32 CA124334/CA/NCI NIH HHS/United States
- R01AI079110/AI/NIAID NIH HHS/United States
- R01AI089539/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous